Climb Bio (CLYM) Other Non Operating Income (2020 - 2026)
Climb Bio (CLYM) posted Other Non Operating Income of -$25000.0 for Q1 2026, up 45.65% on a QoQ basis from -$46000.0 in Q4 2025, and up 50.0% year-over-year from -$16666.7 in Q1 2025.
Climb Bio (CLYM) Other Non Operating Income (2020 - 2026) Analysis & Trends
Climb Bio's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$25000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 50.0% year-over-year to -$25000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$266000.0 (down 923.08% YoY) and the FY2025 annual result came in at -$291000.0, down 3133.33% from the prior year.
- Other Non Operating Income was -$25000.0 for Q1 2026 at Climb Bio, up from -$46000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.8 million in Q4 2022 and bottomed at -$934000.0 in Q3 2022.
- A 5-year average of $351647.1 and a median of -$25000.0 in 2026 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 1034.18% — and 2025, when it slumped 8000.0%.
- Climb Bio's Other Non Operating Income stood at $1.8 million in 2022, then retreated by 17.35% to $1.5 million in 2023, then tumbled by 101.76% to -$26000.0 in 2024, then plunged by 76.92% to -$46000.0 in 2025, then jumped by 45.65% to -$25000.0 in 2026.
- Business Quant data shows CLYM's Other Non Operating Income at -$25000.0 in Q1 2026, -$46000.0 in Q4 2025, and -$33000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25,000.00 |
| Dec 31, 2025 | -46,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -162,000.00 |
| Mar 31, 2025 | -50,000.00 |
| Dec 31, 2024 | -26,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 1.49 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 1.79 Mn |
| Sep 30, 2022 | -934,000.00 |
| Jun 30, 2022 | -895,000.00 |
| Mar 31, 2022 | -157,000.00 |
| Dec 31, 2021 | 158,000.00 |
| Sep 30, 2021 | -232,000.00 |
| Jun 30, 2021 | -12,000.00 |